Buprenorphine Hcl Tablet
Product Images NDC 70518-2226

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 70518-2226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 2mg 70518 2226 01

Buprenorphine  2mg 70518 2226 01
This is a description of a prescription medication called Buprenorphine (NDC #: 70518-2226-01) manufactured by Hikma Pharmaceuticals USA Inc, based in Eatontown, NJ. It is a 2mg sublingual tablet, with the tablet code labeled as C-ll. The prescription comes in a bottle with a quantity of 30 tablets and the directions for use can be found in the package insert. It is important to keep all medications, including this one, out of reach of children. The medication should be stored within a temperature range of 2-25°C (63.77°F); excursions permitted to 15-30°C (50.86°F) [Ses USP]. The medicine is labeled for prescription use only and comes from RemedyRepack Inc., based in Indiana, PA 15701.*
FDA Label Image

Buprenorphine 2mg 70518 2226 02

Buprenorphine  2mg 70518 2226 02
This is a medication called Buprenorphine, which comes in the form of 2mg sublingual tablets made by Hikma Pharmaceuticals USA Inc. It is sold in a package containing 60 tablets, with the National Drug Code (NDC) 70518-2226-02. The drug should be kept out of reach of children, and stored at a temperature between 20-25°C (63.77°F), with permitted excursions up to 15-30°C (50.86°F), according to USP standards. The drug's usage directions can be found in the package insert, and federal law prohibits its transfer to anyone other than the patient for whom it was prescribed. The medication was repackaged by RemedyRepack Inc. in Indiana, PA 15701.*
FDA Label Image

Buprenorphine 2mg 70518 2226 03

Buprenorphine  2mg 70518 2226 03
This is a description of buprenorphine medication in the form of sublingual tablets. The medication has an NDC number and lot number, and is manufactured by Hikma Pharmaceuticals USA Inc. The medication is packaged in a quantity of 90 tablets and has the caution that it should only be used by the patient for whom it was prescribed. The tablets must be stored within a specific temperature range, as described in the USP, and should be kept out of reach of children. The medication was repackaged by RemedyRepack Inc.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Buprenorphine is a medication produced by Hikma Pharmaceuticals USA Inc, in Eatontown, NJ. The medication is in the form of a sublingual tablet, labeled C-ll, with a strength of 2 mg. The National Drug Code (NDC) for Buprenorphine is 70518-2226-00. The LOT # of the medication is not available. The sublingual source NDC for this medication is 00054-0176-13. It is recommended to store this drug at temperatures between 20-25°C (68-77°F), and excursions permitted are 15-30°C (59-86°F). The medication must be kept out of reach of children. The package insert should be consulted for directions for use. The medication is available in a package of 30 tablets. Federal law prohibits the transfer of this drug to anyone other than the patient for whom it was prescribed. This medication has been repackaged by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Bup HCl Chem Fig

FDA Label Image

Ifu Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.